No benefit of induction chemo, high-dose boost in anal cancer
(HealthDay) -- Neither induction chemotherapy (ICT) nor high-dose radiation boost is associated with an improvement in five-year colostomy-free survival (CFS) in patients with locally advanced anal canal carcinoma (LAACC), ...
Apr 26, 2012
0
0